Considerable evidence supports a defect at the level of chromatin structure or recognition of that structure in cells from patients with the human genetic disorder ataxia-telangiectasia. Accordingly, we have investigated the activities of enzymes that alter the topology of DNA in Epstein Barr Virus-transformed lymphoblastoid cells from patients with this syndrome. Reduced activity of DNA topoisomerase II, determined by unknotting of P4 phage DNA, was observed in partially purified extracts from 5 ataxia-telangiectasia cell lines. The level of enzyme activity was reduced substantially in 4 of these cell lines and to a lesser extent in the other cell line compared to controls. DNA topoisomerase I, assayed by relaxation of supercoiled DNA, was found to be present at comparable levels in both cell types. Reduced activity of topoisomerase II in ataxia-telangiectasia is compatible with the molecular, cellular and clinical changes described in this syndrome.
INTRODUCTION
Over the last several years a variety of multidisciplinary approaches have been employed in attempts to unravel the nature of the biochemical defect in the human autosomal recessive disorder ataxia-telangiectasia (A-T). This syndrome is characterized by progressive neuronal degeneration (1, 2) , severe immunodeficiency (3, 4) , chromosome instability (spontaneous and radiation-induced) (5, 6) , and predisposition to cancer (7, 8) . Increased sensitivity to ionizing radiation and radiomimetic chemicals has been widely reported in cells from these individuals (9) (10) (11) (12) . Other molecular and cellular characteristics observed in this syndrome include; damage resistant DNA synthesis (13) (14) (15) (16) (17) (18) , reduced DNA repair (19, 20) , abnormal DNA rearrangements (21, 22) , and reduced capacity to rejoin restriction endonuclease-induced double strand breaks in recombinant plasmids (23) . These features are consistent with a defect at the level of chromatin structure or the recognition of that structure. It has been suggested that the defect in A-T is in the processing of DNA damage caused by free radicals (24) . Preliminary results from this laboratory presented evidence for a defect in DNA topoisomerase activity in nuclear extracts from A-T cells (25) .
DNA topoisomerases are enzymes that control and alter the topological states of DNA in both prokaryotes and eukaryotes (26) . Eukaryotic topoisomerase I introduces transient single strand breaks into DNA and in this way catalyzes the relaxation of supercoiled DNA.
Topoisomerase II from eukaryotic cells catalyzes the relaxation of supercoiled DNA molecules, catenation, decatenation, knotting and unknotting of circular DNA (26) . It appears likely that the reaction catalyzed by topoisomerase II involves the crossing-over of two DNA segments by an enzyme-bridged strand-passing mechanism. Miller et ai, (27) have estimated that there are about 105 topoisomerase II molecules per HeLa cell nucleus, constituting about 0.1% of the nuclear extract. Topoisomerase II has been demonstrated to be a major polypeptide component of the Drosophila nuclear matrixpore complex and a major scaffolding protein of chicken mitotic chromosomes (28, 29) . More recently Cockerill and Garrad (30) , have provided evidence for the presence of topoisomerase II binding sites within the K nuclear matrix association region (MAR) just upstream of the enhancer. While roles for prokaryotic topoisomerases in DNA replication, recombination and transcription have been described, considerably less information is available on eukaryotic topoisomerases. This enzyme is necessary for the segregation of chromosomes at the termination of DNA replication and for the normal segregation of sister chromatids at mitosis (31) . Use of temperature-sensitive mutants of yeast have provided evidence for an essential role of topoisomerase II in maintaining cell viability (32) . Since several of the characteristics of A-T appear to be due to abnormalities in DNA processing we have screened a number of A-T cell lines for DNA topoisomerase activity. Our results, using partially purified preparations, demonstrate that topoisomerase II activity is reduced in all of the A-T cell lines assayed. Topoisomerase I was found to be present at similar levels in both cell types.
MATERIALS AND METHODS
Epstein-Barr Virus-transformed lymphoblastoid cell lines, grown in suspension culture, in RPMI1640 medium, supplemented with 10% foetal calf serum, were used in this study. The A-T cell lines were AT1ABR, AT3ABR, AT4ABR and AT8ABR. Control lines were C2ABR, C12ABR and C17ABR. Enzyme purification Partial purification of topoisomerase II was carried out by a modification of previously described methods (27, 33) . Freshly cultured cells (4 x 1010) were pelleted by centrifugation (3,000 g, 10 min) washed twice with wash buffer (0.15 M NaCl, 10 mM sodium phosphate, pH 7.5) and resuspended in 100 ml of nuclear extraction buffer (5 mM potassium phosphate, pH 7.0, 2 mM MgCl2, 1 mM phenylmethylsulphonyl fluoride (PMSF), 1 mM P-mercaptoethanol, 0.5 mM dithiothreitol (DTT), 0.1 mM EDTA). The cells were stored on ice for 30 min prior to disruption by Dounce homogenization for 3 min at low speed (disruption was monitored by phase microscopy), and nuclei collected by centrifugation (200 g, 10 min). Nuclei were resuspended in wash buffer and EDTA added to a final concentration of 4 mM. After standing on ice for 15 min the nuclei were lysed by the slow addition of equal volumes of lysis buffer (2M NaCl, 50 mM Tris-HCl, pH 7.5, 10 mM (J-mercaptoethanol, 1 mM PMSF) and 18% (W/V) PEG, 1 M NaCl, 50 mM Tris-HCl.pH 7.5, 10 mM P-mercaptoethanol, 1 mM PMSF, kept on ice for 40 min and centrifuged (12,000 g, 30 min) to prepare a PEG supernatant. This supernatant was then applied to a hydroxylapatite column (1.5 cm x 10 cm, Bio-Rad) and the column developed with a 100 ml linear gradient of 0.2M to 0.7M potassium phosphate buffer, pH 7.0, according to Halligan et a!., (33) . Topoisomerase n activity eluted between 370 and 460 mM potassium phosphate, approximately the same position for control and A-T extracts. All fractions having type II activity were combined (some overlap with topoisomerase I activity occured) and applied to a blue Sepharose column (1.5 cm x 6 cm, Cibacron blue 3GA coupled to Sepharose 6B-CL, Pharmacia) and topoisomerase II step-eluted with 1% Triton x-100, 2M NaCl according to Halligan et al., (33) . Topoisomerase n-containing fractions were combined and loaded onto a hydroxylapatite column (1 cm x 5 cm) for concentration. The column was washed with buffer containing 0.2 M potassium phosphate buffer, pH 7.0, 10% glycerol, 10 mM pmercaptoethanol, 1 mM PMSF, followed by the step-elution of the topoisomerase II activity with 10 ml of 0.7 M potassium phosphate, pH 7.0, and the same buffer constituents. Fractions having topoisomerase II activity were pooled and dialysed against storage buffer (30 mM potassium phosphate, pH 7.0, 50% glycerol, 0.5 mM DTT, 0.1 mM EDTA), and stored at -20°C. The protein recoveries, as measured by the method of Bradford (34) were comparable in A-T and control cell lines and were of the order of 0.16% of the total protein from the PEG supernatant.
Partial purification of topoisomerase I was carried out essentially as described for toporisomerase II. After elution of the topoisomerase I activity, the bulk of which eluted at a higher phosphate concentration than topoisomerase II on the hydroxylapatite column (between 400 and 680 mM potassium phosphate), active fractions (containing no measurable topoisomerase n activity) were pooled and used for further purification as described above using blue Sepharose followed by concentration, and dialysis against storage buffer. The recovery of protein in control and A-T cell lines were comparable, and was of the order of 0.18% of the total protein from the PEG supernatant. Preparation of nuclear extracts Crude nuclear protein extract from AT8ABR was prepared by pelleting 4 x 107 cells from a freshly grown suspension culture by centrifugation (5000 g, 10 min). The pellet was washed with extraction buffer, 50 mM Tris-HCl, pH 7.5, 25 mM KC1, 3 mM MgCh, 0.25 M sucrose, 1 mM PMSF, 2 mM DTT, 1 mM EDTA, and resuspended in 2 ml of the above buffer. Cells were homogenized in a Dounce homogenizer at 0°C until 98% of the cells were disrupted. The homogenate was then adjusted to 400 mM with respect to KC1 and centrifuged (23,000 g, 60 min). The supernatant was collected and adjusted to 70% saturation with (NH4)2SO4 and stirred for 30 min. The precipitated proteins were collected by centrifugation (15,000 g, 15 min) and redissolved in 0.5 ml of extraction buffer and dialysed against storage buffer, 40 mM TrisHCl.pH 7.5, 2 mM DTT, 1 mM EDTA, 0.25 M sucrose, and stored at -20°C. Topoisomerase assays Topoisomerase II activity was determined by unknotting of P4 phage DNA according to Liu et al., (35) . P4 phage and bacterial strains were provided by Leroy Liu, John Hopkins Medical School, Baltimore. Reaction mixtures (20|j.l) contained 50 mM Tris-HCl, pH 7.7, 100 mM KC1, 10 mM MgCh, 0.5 mM EDTA, 10-50(Xg/ml P4 DNA and increasing amounts of topoisomerase n protein. After a 1 h incubation at 37°C reactions were terminated by the addition of 5(0.1 of 5% SDS, 50 mM EDTA, 20% Ficoll, 50|ig/ml bromophenol blue. Activity was determined by conversion of knotted DNA to circular form by agarose gel electrophoresis.
Topoisomerase I activity was determined by the ATP-independent relaxation of supercoiled plasmid pRl-2 (provided by U. Novak, University of Melbourne). Reaction mixtures (30|il) contained 40 mM Tris-HCl, pH 8.1, 20 mM MgCl 2 , 1 mM EDTA, 40 mM KC1, 20 mM spermidine, 60(ig/ml bovine serum albumin, 30% (W/V) glycerol, 1 mM DTT, 0.8|J.g pRl-2 supercoiled DNA and increasing amounts of partially purified topoisomerase I protein.
Incubations were carried out for 1 h at 37°C and terminated with 5jxl of 2.5% SDS, 25 mM EDTA, 25% glycerol and 0.03% bromophenol blue. Activity was determined by electrophoresis on agarose gels.
RESULTS
In order to overcome problems from nuclease and other interfering activities DNA topoisomerases were assayed in partially purified preparations from control and A-T cells. Partial purification was carried out as described in Materials and Methods, involving nuclear extraction, followed by hydroxylapatite and blue Sepharose chromatography. Topoisomerase n activity was determined by the unknotting of naturally knotted P4 phage DNA isolated from tailless phage as described previously (33) . This assay has the advantage that it is not interfered with by topoisomerase I activity. In this assay, randomly knotted DNA molecules are converted to unknotted circular DNA molecules. The results in Figure 1 provide a comparison of topoisomerase II activity in partially purified A-T and control preparations. In the case of controls a concentration dependent increase in circular DNA is observed (Figure 1 a, b, c) . Some variability in the extent of reaction in the control group is found. However, by comparison topoisomerase II activity is considerably reduced in A-T extracts. In each pair (a, b or c) A-T and control extracts were prepared and assayed at the same time. ATI ABR ( expressed in units, but based on the increase in circular DNA the activity of topoisomerase II in both A-T extracts appears to be reduced greater than 10-fold. This difference in activity between control and A-T extracts was observed over a range of DNA concentrations but less obvious at lower concentrations. The reduction in activity in the third A-T cell line, AT3ABR, was considerably less, the difference in activity being more obvious at higher enzyme concentrations. Comparison of AT8ABR and C12ABR extracts for supercoil relaxation activity gave results very similar to those in Figure 1 b with A-T again showing much reduced activity (results not shown). In both assays there was a requirement for ATP for activity. Time course studies at a single protein concentration (50 ng/incubation) provided additional support for the protein concentration data. In this case also the rate of topoisomerase II activity was markedly reduced in two A-T cell lines used above (Figure 2 a, b) and in an additional line, AT4ABR (Figure 2 c) , compared to the corresponding control activities. We have also demonstrated that topoisomerase II activity is reduced in a fifth lymphoblastoid A-T cell line (results not shown).
Either topoisomerase I or II is sufficient to provide the unlinking activity required for fork propagation during SV40 replication (36) , and at least some topoisomerase activity is required throughout the yeast cell cycle (37) . Because of this relationship between the two activities we also measured topoisomerase I activity in partially purified extracts from A-T and controls. The results in Figure 3 , using ATP-independent relaxation of supercoiled plasmid as abcdef Form IrForm I-C 1 2ABR AT8ABR Figure 3 Comparison of topoisomerase I activity in partially purified A-T and control preparations. Topoisomerase I activity was measured by the ATP-independent relaxation of supercoiled plasmid pRl-2. Analysis was carried out by agarose gel electrophoresis as described in legend to Figure 1 . Lanes a-g and lanes h-n represent increasing amounts of control and A-T topoisomerase I protein respectively. The protein concentration range was the same as that described in Figure 1 .
an assay, demonstrate that topoisomerase I levels are remarkably similar in AT8ABR and C12ABR cell lines. Topoisomerase I activity was comparable in other control and A-T cell lines (results not shown).
Since it was possible that the reduced topoisomerase II activity in A-T extracts could be accounted for by the inhibitory effects of another protein, we carried out mixing experiments. When a sample of crude nuclear extract from A-T cells was added to partially purified extract from either control or A-T no appreciable effect on topoisomerase II was observed (Figure 4 ). Similarly the partially purified A-T extracts, when added to control extracts, did not markedly reduce topoisomerase II activity (results not shown).
It has previously been demonstrated that the activity of topoisomerase n varies considerably with the growth phase of the cells (38) . Since the doubling times of the A-T and control lymphoblastoid cells used in this study are similar (approximately 30 h), it is very unlikely that growth state can account for the differences in activity of topoisomerase II. In addition analysis of the cells using a fluorescent activated cell sorter (FACS IV) revealed that the proportion of cells in S phase was similar in all the cell lines (data not shown). Preferential loss of topoisomerase II activity into the cytoplasm, during the extraction procedure, was ruled out as a possible artefact.
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DISCUSSION
Hypersensitivity of cultured A-T cells, as determined by cell survival (39) and elevated retention in G2 phase (40) , have been observed after exposure to etoposide (VP-16-213), an inhibitor of topoisomerase II. A major cytokinetic effect of inhibitors of topoisomerase II is a G2 phase block, which is also observed at an abnormally high level in irradiated A-T cells (41) . Increased chromosome breakage and instability in A-T cells as well as a reduced capacity to repair radiation-induced double strand breaks in DNA, in the Gl phase of the cell cycle, are also in keeping with reduced topoisomerase II activity (6, 20) . In addition Debenham et al. (42) , have shown that unirradiated A-T cells are more sensitive to killing by novobiocin (an inhibitor of topoisomerase II) although it should be pointed out that novobiocin does have other effects. Misrepair of double-stranded DNA scissions occurs at an elevated frequency in restriction endonuclease cleaved recombinant plasmids, introduced by transfection into A-T cells (43) . Cox et al., (23) suggested that this misrepair was due to a disequilibrium between ligation and exonuclease digestion of DNA termini or changes in a secondary factor that maintains the equilibrium position. Clearly topoisomerase II would be an appropriate candidate for the unknown secondary factor that Cox et a/.invoke to moderate exonuclease activity by complexing with the damaged DNA sites. The data obtained in the present study together with the evidence outlined above provide support for a role for topoisomerase II in the repair of double strand breaks in DNA. Previous studies have demonstrated that topoisomerase II can cleave double-stranded DNA and remain covalently bound at each of the 5' -ends generated (44) , but no evidence for its ability to bind and rejoin free ends exists. Nevertheless, it is not inconceivable that a double strand break in chromatin, induced by ionizing radiation or another damaging agent, would be recognized and bound by topoisomerase n, perhaps mediated by other nuclear factors, and subsequently rejoined.
The reduced topoisomerase II activity reported here for several A-T cell lines could be due to an amino acid substitution interfering with the active site of the enzyme rendering it more labile, greater susceptibility to specific proteolytic cleavage or to a defect in post-translational modification. It is also posible that another protein associated with topoisomerase II is defective or that a reduction in the effective concentration of ATP in A-T extracts is responsible for the reduced activity.
While doubling time was not markedly different in control and A-T cells in this study, some abnormalities in cell cycle behaviour have been described in A-T cells. The reduced activity of topoisomerase II may be inherently related to cell cycle events other than those controlling actual growth rate. Finally, the very substantial difference in topoisomerase II activity that we observe here may not reflect acurately the situation in the cell, since the reduction in activity could be exaggerated by displacement of the enzyme from its location in the nuclear matrix. Further purification of topoisomerase II from control and A-T cells and subsequent gene cloning are important priorities for the elucidation of the exact biochemical defect in A-T.
